{"id":"experimental-empiric-tb-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Hepatotoxicity"},{"rate":null,"effect":"Peripheral neuropathy"},{"rate":null,"effect":"Gastrointestinal disturbance"},{"rate":null,"effect":"Hyperuricemia"},{"rate":null,"effect":"Rash"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Empiric TB treatment typically combines first-line agents such as isoniazid, rifampicin, pyrazinamide, and ethambutol, each inhibiting different aspects of mycobacterial cell wall synthesis, DNA replication, or metabolism. This multi-drug approach is standard practice to rapidly reduce bacterial burden and prevent the emergence of drug-resistant strains during the intensive phase of treatment.","oneSentence":"Empiric TB treatment is a combination regimen of multiple anti-tuberculous agents designed to target Mycobacterium tuberculosis through different mechanisms to prevent drug resistance.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:29:59.635Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tuberculosis (pulmonary and extrapulmonary)"}]},"trialDetails":[{"nctId":"NCT01417988","phase":"PHASE4","title":"Prevention of Early Mortality by Presumptive Tuberculosis (TB) Treatment","status":"TERMINATED","sponsor":"Prof JMA Lange","startDate":"2011-08","conditions":"HIV Infection, Tuberculosis","enrollment":44}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Experimental: Empiric TB treatment","genericName":"Experimental: Empiric TB treatment","companyName":"Prof JMA Lange","companyId":"prof-jma-lange","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Empiric TB treatment is a combination regimen of multiple anti-tuberculous agents designed to target Mycobacterium tuberculosis through different mechanisms to prevent drug resistance. Used for Tuberculosis (pulmonary and extrapulmonary).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}